Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Nov 19.
Published in final edited form as: J Nucl Med. 2012 Sep 11;53(11):1807–1813. doi: 10.2967/jnumed.112.106138

RADAR Reference Adult, Pediatric, and Pregnant Female Phantom Series for Internal and External Dosimetry

Michael G Stabin 1, X George Xu 2, Mary A Emmons 1, W Paul Segars 3, Chengyu Shi 2, Michael J Fernald 1
PMCID: PMC4652945  NIHMSID: NIHMS736228  PMID: 22967805

Abstract

A new generation of reference computational phantoms, based on image-based models tied to the reference masses defined by the International Commission on Radiological Protection (ICRP) for dose calculations, is presented.

Methods

Anatomic models based on nonuniform rational b-spline modeling techniques were used to define reference male and female adults, 15-y-olds, 10-y-olds, 5-y-olds, 1-y-olds, newborns, and pregnant women at 3 stages of gestation, using the defined reference organ masses in ICRP publication 89. Absorbed fractions and specific absorbed fractions for internal emitters were derived using standard Monte Carlo radiation transport simulation codes.

Results

Differences were notable between many pairs of organs in specific absorbed fractions because of the improved realism of the models, with adjacent organs usually closer and sometimes touching. Final estimates of absorbed dose for radiopharmaceuticals, for example, were only slightly different overall, as many of the differences were small and most pronounced at low radiation energies. Some new important organs were defined (salivary glands, prostate, eyes, and esophagus), and the identity of a few gastrointestinal tract organs changed.

Conclusion

A new generation of reference models for standardized internal and external dose calculations has been defined. The models will be implemented in standardized software for internal dose calculations and be used to produce new standardized dose estimates for radiopharmaceuticals and other applications.

Keywords: computational phantoms, dosimetry, Monte Carlo calculations


Anthropomorphic models—also called computational phantoms—applied for dose calculations in nuclear medicine for the past 30 y have used the stylized geometric definitions that were developed for reference adults and children (1) and pregnant women (2). Figure 1 shows an exterior view of one of the Cristy/Eckerman stylized adult and pediatric models. The models’ exteriors were defined in 3 sections: an elliptic cylinder representing the arm, torso, and hips; a truncated elliptic cone representing the legs and feet; and an elliptic cylinder representing the head and neck. Several organs and tissues were mathematically defined as occupying finite spaces within the body space and comprised 3 types of tissue: soft tissue, bone, and lung. The mathematic descriptions of the organs were formulated on the basis of descriptive and schematic materials from general anatomy references. This series of stylized models was implemented in the MIRDOSE (3) and OLINDA/EXM 1.0 (4) personal computer codes to facilitate calculation of standardized internal dose calculations.

FIGURE 1.

FIGURE 1

Exterior view of one of the Cristy/Eckerman 1987 phantoms (1).

The stylized models that originated at Oak Ridge National Laboratory some 40 y ago have now been replaced with realistic body models based mostly on human image data (5). The image-based models are now considered to be the second-generation anatomic models that use the so-called voxel geometry. Petoussi-Henss et al. created tomographic voxelized models from CT images (6) and found that the stylized computational models could over- and underestimate organ absorbed fractions by several tens of percentage points when compared against the more realistic, image-based models. Similar discrepancies between the stylized and voxelized models were reported using the VIP-Man model, which is based on the Visible Human Project cadaver cross-sectional anatomic images (7,8). Hurtado et al. (9) reported on hybrid realistic computational phantoms for adults and used them in retrospective dosimetry analyses for contaminated radiation workers. Many others have developed individual realistic phantoms of adults (10,11), children (12), and pregnant women (13,14), using various technologies, as summarized by Xu and Eckerman (5). In particular, representing the third generation of anatomic model is the work by Segars, now with Duke University, who used the nonuniform rational b-spline (NURBS) modeling technique (15) that has allowed not only a more realistic rendering of the human body but also the attractive capability of rapid and easy scaling of organs and the whole body. Figure 2 shows the adult male and female NURBS models originally developed by Segars.

FIGURE 2.

FIGURE 2

Anterior views of Segars (15) NURBS models of adult male (A) and adult female (B).

This work describes the development of a complete male and female adult and pediatric (15-y-old, 10-y-old, 5-y-old, 1-y-old, and newborn) and pregnant woman phantom series for the purposes of internal radiation dosimetry in nuclear medicine using a realistic, NURBS-based body modeling technique, based on the recommended organ, body, and fetal masses in publication 89 of the International Commission on Radiological Protection (ICRP) (16). We have calculated photon- and electron-specific absorbed fractions (SAFs) and dose factors for more than 1,000 radionuclides for this phantom series, as defined in the unified internal and external dose assessment methodology of the RAdiation Dose Assessment Resource (RADAR) for nuclear medicine patient and occupational radiation worker dosimetry (17):

D=kÃiniEiϕim=kÃiniEiΦi

where D is absorbed dose in a target organ (rad or Gy), Ã is cumulated activity (sum of all nuclear transitions that occurred) in a source organ (µCi-h or MBq-s), n is number of radiations with energy E emitted per nuclear transition, E is energy per radiation (MeV), φ is absorbed fraction (fraction of radiation energy absorbed in the target), m is mass of target region (g or kg), Φ is SAF (=φ/m [g−1 or kg−1]), and k is a proportionality constant (rad-g/µCi-h-MeV or Gy-kg/MBq-s-MeV).

In certain cases (e.g., hollow organs and bone or marrow), results from other models are used to provide a complete dosimetric modeling environment that has been implemented for internal dose assessment in an update of the OLINDA/EXM personal computer code (4).

MATERIALS AND METHODS

Adult and Pediatric Models

NURBS models may be easily deformed to represent different sizes and shapes. We developed a series of models representing adults and children of different ages scaled from these original adult models to match the recommended age-dependent organ masses given in ICRP publication 89 (16). Existing software tools developed by Segars allow for the rapid scaling of human NURBS. One or more selected organs may be translated or rotated in any direction, scaled linearly in any direction (uniformly in 3 dimensions from the center by a fixed factor), and otherwise modified by the user. Slice-by-slice viewing of results is also afforded by this software tool. We started with Segars’ 2 adult models, scaled them to the ICRP 89 reference adult organ masses, and then continued to modify them to represent the smaller models by deforming the surfaces and then adjusting the organs to match the ICRP 89 models for each age. In general, the whole models were not simply scaled equally in all 3 dimensions; for example, the head size is much larger relative to the size of the whole body in young children than in adults. Overall scaling of the body was done to provide an appropriate body size and shape, and then organs were individually scaled. The ICRP 89–recommended organ mass values for adults and children of various reference ages (male and female newborn, 1-y-old, 5-y-old, 10-y-old, 15-y-old, and adult) were used as target masses for individual organs in each phantom. Mostly, organs were varied in all 3 dimensions equally, and then individual organs could be translated if needed to maintain internal consistency between the models. Age-dependent differences (e.g., head size in young children) were incorporated. When finalized, the modified models were rendered in voxel format with another software tool (using a resolution of 1.5 × 1.5 × 5 mm) and converted from binary to ASCII format. Hollow organs had both wall and content components; target masses from ICRP 89 were applied to both the wall and the content components. Organs were touching and even overlapping in some cases; Segars’ models have a priority scheme to handle this, which is invoked during voxelization. All original file sizes were 512 × 512 × 512; these were trimmed to a variable cubic format that eliminated excess rows and columns of voxels outside the phantom and were used with a GEANT4 (GEometry ANd Tracking)-based (18) Monte Carlo radiation transport program that we developed. Separate male and female models were made for the adult and pediatric models. Because the ICRP does not offer separate organ mass values for 10-y-old models and younger, the same model was used for both sexes, with the sex organs added as appropriate. For most organs, the difference between the NURBS reported and voxelized volumes were usually within 1%; for some small organs, however, the differences were sometimes greater. Absorbed fractions were converted to SAFs using the reference organ masses (Tables 1 and 2). Generally, 200,000 starting particles were used at each energy for each source organ. Uncertainties in calculated SAF values were generally less than 5% for most organs; for some small or distant organs or very low-energy particles, the uncertainties were necessarily higher. Reciprocity (19), averaging, and curve-smoothing methods were used to deal with noisier data. Many values at low energies were of high uncertainty or no hits were observed; these were reported as zeroes, and no attempts were made to extrapolate curves beyond the range of the reported data. For the pregnant female models, as noted by Shi et al. (14): “The Monte Carlo run employed approximately 1 × 107 histories to keep the statistical uncertainty to less than 10% for most of the target organs, except for photon energies below 30 keV and for some target organs that were too small or too far from the source organ. In the latter cases, uncertainties of 10% or more were observed. The results were discarded if the relative uncertainty was higher than 40% so we could include as many data points as possible. The cutoff energy for both electron and photon calculations in the EGS4-VLSI user code were set to be 10 keV.”

TABLE 1.

Selected Reference Organ Masses (g) for Pediatric/Adult Phantom Series

Newborn 1-y-old 5-y-old 10-y-old 15-y-old Adult






Organ/Tissue Female Male Female Male Female Male Female Male Female Male Female Male
Adrenals 6 6 4 4 5 5 7 7 9 10 13 14

Brain 380 380 950 950 1,180 1,310 1,220 1,400 1,300 1,420 1,300 1,450

Breasts 0 0 0 0 0 0 0 0 250 15 500 25

Esophagus 2 2 5 5 10 10 18 18 30 30 35 40

Eyes 6 6 7 7 11 11 12 12 13 13 15 15

Gallbladder wall 0.5 0.5 1.4 1.4 2.6 2.6 4.4 4.4 7.3 7.7 8 10

Left colon 7 7 20 20 49 49 85 85 122 122 145 150

Small intestine 30 30 85 85 220 220 370 370 520 520 600 650

Stomach wall 7 7 20 20 50 50 85 85 120 120 140 150

Right colon 7 7 20 20 49 49 85 85 122 122 145 150

Heart wall 20 20 50 50 85 85 140 140 220 230 250 330

Kidneys 25 25 70 70 110 110 180 180 240 250 275 310

Liver 130 130 330 330 570 570 830 830 1,300 1,300 1,400 1,800

Lungs 60 60 150 150 300 300 500 500 750 900 950 1,200

Muscle 800 800 1,900 1,900 5,600 5,600 11,000 11,000 17,000 24,000 17,500 29,000

Ovaries 0.3 0 0.8 0 2 0 3.5 0 6 0 11 0

Pancreas 6 6 20 20 35 35 60 60 100 110 120 140

Prostate 0 0.8 0 1 0 1.2 0 1.6 0 4.3 0 17

Rectum 3 3 10 10 22 22 40 40 56 56 70 70

Salivary glands 6 6 24 24 34 34 44 44 65 68 70 85

Red marrow 50 50 150 150 340 340 630 630 1,000 1,080 900 1,170

Bone surfaces 4.21 4.21 13.7 13.7 33 33 56 56 92 92 120 120

Spleen 9.5 9.5 29 29 50 50 80 80 130 130 130 150

Testes 0 0.85 0 1.5 0 1.7 0 2 0 16 0 35

Thymus 13 13 30 30 30 30 35 40 30 35 20 25

Thyroid 1.3 1.3 1.8 1.8 3.4 3.4 7.9 7.9 12 12 17 20

Urinary bladder wall 4 4 9 9 16 16 25 25 35 40 40 50

Uterus 4 0 1.5 0 3 0 4 0 30 0 80 0

Total body 3,500 3,500 10,000 10,000 19,000 19,000 32,000 32,000 53,000 56,000 60,000 73,000

TABLE 2.

Selected Reference Organ Masses (g) for RPI Pregnant Female Phantom Series

Organ/Tissue 3 mo 6 mo 9 mo
Adrenals 13 13 13

Brain 1,299 1,299 1,299

Breasts 570 797 906

Fetus 85 1,115 3,495

Gallbladder contents 48 48 48

Heart contents 370 370 370

Heart wall 250 250 250

Kidneys 275 275 275

Liver 1,400 1,400 1,400

Lower intestine contents* 320 320 320

Lungs 950 950 950

Ovaries 11 11 11

Pancreas 120 120 120

Placenta 48 319 650

Small intestine contents 880 880 880

Spleen 130 130 130

Stomach contents 231 231 231

Thymus 20 20 20

Thyroid 17 17 17

Urinary bladder contents 129 129 129

Uterus 270 550 1,047
*

“Lower intestine” in these models is ascending, transverse, descending, and sigmoid colon, with wall and content sections.

Pregnant Female Models

A complete description of the methods used to develop SAFs for the pregnant female models developed at Rensselaer Polytechnic Institute (RPI) in collaboration with Vanderbilt has been published previously (13,14). Briefly, organ models were created by extracting the voxel information contained in the so-called boundary representations that consisted of polygonal meshes or NURBS. Individual organs and fetal models were integrated into the adult female whole body by careful adjustment of the organ shape and location to accommodate gestation-related anatomic changes in the body and to avoid organ overlap. For each organ, the volume and mass were specified manually according to reference values recommended in ICRP 89 (16). Once all the organs and total body weights had been adjusted, the surface models were voxelized for dose calculations using the EGS4 Monte Carlo code (20).

RESULTS

Figure 3 shows images of selected models from the adult and pediatric ICRP 89 phantom series, and Figure 4 shows renderings of the RPI pregnant female models. Figure 5 shows sample photon and electron SAFs for adult and pediatric models. Traditionally, all AFs for electron self-irradiation have been assumed to be 1.0 for an organ irradiating itself and 0.0 for other organs. Although this trend is generally true, when electron transport is performed there is some departure from this assumption at higher energies. This trend is more important for the smaller organs, particularly in the smaller phantoms.

FIGURE 3.

FIGURE 3

Rendering of selected NURBS ICRP 89 phantoms: newborn female model (A), 5-y-old male model (B), 10-y-old female model (C), and 15-y-old male model (D).

FIGURE 4.

FIGURE 4

Rendering of 3-dimensional organ and body surfaces for RPI pregnant female models: 3 mo (A), 6 mo (B), and 9 mo (C).

FIGURE 5.

FIGURE 5

Sample SAF plots for ICRP 89 pediatric and adult models: male, photons stomach←liver (A), female, photons lungs←lungs (B), male, electrons kidneys←kidneys (C), and female, adrenals←kidneys (D).

DISCUSSION

The first generation of stylized anthropomorphic models has served the dosimetry community well for over 40 y for internal and external dose applications (5). Original body models used in dosimetry were spheric (21); this was mathematically convenient and provided conservative estimates of SAFs and doses but was not at all realistic, and there was no provision for organ cross-irradiation. The development of the stylized adult and pediatric phantom series by Cristy and Eckerman (1) (following the original design of Snyder et al. (22)) represented an important incremental change in methods for development of SAFs and a significant increase in model realism over a simple, uniform sphere. Monte Carlo methods were developed to estimate SAF values for the organs, and the science of dose calculations for internal and external simulated sources of radiation was greatly improved. However, the advent of image-based technologies that allowed the development of realistic body models for use in dose calculations brought an exciting opportunity to perform patient-individualized dose calculations in nuclear medicine therapy (23), as well as general dose assessment for internal or external sources. The models presented here represent the third generation of body models, with the organ masses based on those recommended by the ICRP for standardized individuals of various ages (16).

Realistic, voxel-based models derived from real human images have notable differences in organ proximity, compared with the traditional, stylized models, as was illustrated by Stabin and Yoriyaz (24). Organs are closer together, and many are in direct contact with each other (kidneys/adrenals, lungs/heart), whereas in stylized models, separation of organ spaces occurs because of the simplicity of the shapes used to model them. Changes in actual SAF values from the Cristy/Eckerman model series can be observed, but they are mostly small. This provides indirect validation of these results (because validation using physical phantoms is not possible with available technology); we also checked that the SAFs at low photon energies were approximately 1/(organ mass). Because the SAFs are similar to those of the previous generation of phantoms, the impact on calculated dose estimates for radiopharmaceuticals, other internal sources, or external sources should be minor but of interest for evaluation. Photon SAFs for lungs)liver for all 6 ages in the male phantoms demonstrate trends similar to those of the previous stylized phantoms, but the SAFs for the realistic phantoms are generally a bit higher because of the more realistic modeling of organ proximity (one lung actually rests on top of the liver). At very low energies, the differences are more pronounced, but these photons are typically not important to a complete dose assessment for a given radiopharmaceutical. In the adult female for lungs ← liver, significant differences are noted at low energies, but at moderate to high energies the values are similar but still slightly higher. For stomach ← spleen, the NURBS values are several orders of magnitude higher in the keV range and noticeably higher at all energies. In calculation of dose estimates for individual radiopharmaceuticals, doses to most organs are similar, but doses to certain organs (e.g., adrenals and pancreas) may be notably different. However, overall effects on effective dose values are small (to be shown in a subsequent publication).

It is useful to now explicitly treat electron SAFs. The OLINDA/EXM computer code (4) included an approximate correction for loss of electron energy in small objects at high electron energies, based on the AFs developed in unitdensity spheres by Stabin and Konijnenberg (25). Explicit Monte Carlo transport provides a better estimation of this electron energy loss at high energies, which can be noted even for large organs such as kidneys (Fig. 5C) but more dramatically for small organs such as ovaries and testes. Deposition of electron energy on other organs is interesting. In most cases, this is simply a small contribution due to bremsstrahlung radiation, which is known to be an insignificant contribution to the overall dose in any internal dose problem (26). However, in cases in which organs are touching (e.g., kidneys/adrenals), β-energy is deposited in the first few millimeters of the tissue in the adjacent organ as well (Fig. 5D). Because these SAFs are for whole organs, inclusion of this component is not equivalent to averaging photon energy over the entire organ, which will be generally more uniform. But there is energy deposited, and we decided to leave this contribution in the reported SAFs.

Many other groups, including Petoussi-Henss et al. (6), Kramer et al. (28), Xu et al. (7), Zubal et al. (29), Lee et al. (30), and others, have developed standardized phantoms ultimately adopted by the ICRP (27). The ICRP 110 models also are based on the ICRP 89 organ weights but use manually segmented and adjusted organ representations from 2 human subjects. As such, the numeric values of SAFs from these models should be similar to those in the RADAR phantoms, because both model realistic organ geometries and use the same organ masses. Evaluation of several cases shows that this is the case (details to be provided in a later publication). We maintained the OLINDA/EXM 1.0 and 1.1 bone and marrow model (based on the modified Eckerman model) (31); we feel that this is an advantage in that it provides continuity between the codes in this area. We are aware that better models are under development (32), but they are not complete for all ages and sexes at present. We also maintained the traditional model for electron irradiation of hollow organ walls. The ICRP addressed the issue of the conservatism of assuming that the dose to the wall–content interface is one half that to the contents, but only for adults (33). We did explicitly model electron and photon transport using hollow-organ contents as the source, but we could not model the exact locations of sensitive cells in the walls, thickness of mucus layers, and other factors. The photon SAFs from the transport were used, but OLINDA/EXM will use the traditional approach for electrons until more complete data are available.

The RADAR phantom series, including the adult, pediatric, and pregnant female models, will be implemented in future versions of the OLINDA/EXM computer code (4), which has facilitated and standardized dose estimates for many years, building on the technical basis of the previous MIRDOSE software (3). New tables of dose estimates for radiopharmaceuticals in current use—organ doses and effective doses—will be generated with these new SAFs and will serve as an update to these dose estimates using this new generation of anthropomorphic phantoms. OLINDA/EXM still treats only average, whole-organ dose, based on an assumed uniform organ uptake. This approach is certainly appropriate for diagnostic applications, but for new drug applications and clinical evaluations this kind of dosimetry is routinely reported for therapeutic radiopharmaceuticals as well. More advanced methods have been demonstrated by several groups as research applications using 3-dimensional distributions of activity to produce nonhomogeneous dose distributions and dose–volume histograms for patient-individualized anatomic models (23,34). There is no present intention for OLINDA/EXM to treat this kind of detailed dosimetry; the role of this code is to provide average organ doses for standardized models.

CONCLUSION

A new generation of reference models for standardized internal and external dose calculations has been defined. The models will be implemented in standardized software for internal dose calculations and be used to produce new standardized dose estimates for radiopharmaceuticals and other applications.

ACKNOWLEDGMENT

Work on this project was supported by grant NIH/NCI 1R42CA115122.

Footnotes

DISCLOSURE STATEMENT

The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.

No other potential conflict of interest relevant to this article was reported.

REFERENCES

  • 1.Cristy M, Eckerman K. Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. Oak Ridge, TN: Oak Ridge National Laboratory; 1987. pp. 1–110. ORNL/TM-8381 V1-V7. [Google Scholar]
  • 2.Stabin M, Watson E, Cristy M, et al. Mathematical Models and Specific Absorbed Fractions of Photon Energy in the Nonpregnant Adult Female and at the End of Each Trimester of Pregnancy. Oak Ridge, TN: Oak Ridge National Laboratory; 1995. pp. 1–140. ORNL/TM-12907. [Google Scholar]
  • 3.Stabin M. MIRDOSE: the personal computer software for use in internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538–546. [PubMed] [Google Scholar]
  • 4.Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023–1027. [PubMed] [Google Scholar]
  • 5.Xu XG, Eckerman KF. Handbook of Anatomical Models for Radiation Dosimetry. Boca Raton, FL: Taylor and Francis; 2009. pp. 1–721. [Google Scholar]
  • 6.Petoussi-Henss N, Zankl M, Fill U, Regulla D. The GSF family of voxel phantoms. Phys Med Biol. 2002;47:89–106. doi: 10.1088/0031-9155/47/1/307. [DOI] [PubMed] [Google Scholar]
  • 7.Xu XG, Chao TC, Bozkurt A. VIP-Man: an image-based whole-body adult male model constructed from color photographs of the Visible Human Project for multi-particle Monte Carlo calculations. Health Phys. 2000;78:476–486. doi: 10.1097/00004032-200005000-00003. [DOI] [PubMed] [Google Scholar]
  • 8.Chao TC, Xu XG. Specific absorbed fractions from the image-based VIP-Man body model and EGS4-VLSI Monte Carlo code: internal electron emitters. Phys Med Biol. 2001;46:901–927. doi: 10.1088/0031-9155/46/4/301. [DOI] [PubMed] [Google Scholar]
  • 9.Hurtado JL, Lee C, Lodwick D, Goede T, Williams JL, Bolch WE. Hybrid computational phantoms representing the reference adult male and adult female: construction and applications for retrospective dosimetry. Health Phys. 2012;102:292–304. doi: 10.1097/HP.0b013e318235163f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kramer R, Zankl M, Williams G, Drexler G. The Calculation of Dose from External Photon Exposures Using Reference Human Phantoms and Monte Carlo Methods. Part I: the Male (ADAM) and Female (EVA) Adult Mathematical Phantoms. Munich, Germany: Gesellschaft für Strahlenund Umweltforschung; 1982. GSF-Bericht-S-885. [Google Scholar]
  • 11.Schlattl H, Zankl M, Petoussi-Henss N. Organ dose conversion coefficients for voxel models of the reference male and female from idealized photon exposures. Phys Med Biol. 2007;52:2123–2145. doi: 10.1088/0031-9155/52/8/006. [DOI] [PubMed] [Google Scholar]
  • 12.Lee C, Lodwick D, Hasenauer D, Williams JL, Lee C, Bolch WE. Hybrid computational phantoms of the male and female newborn patient: NURBS-based whole-body models. Phys Med Biol. 2007;52:3309–3333. doi: 10.1088/0031-9155/52/12/001. [DOI] [PubMed] [Google Scholar]
  • 13.Xu XG, Taranenko V, Zhang J, Shi C. A boundary-representation method for designing whole-body radiation dosimetry models: pregnant females at the ends of three gestational periods: RPI-P3, −P6 and −P9. Phys Med Biol. 2007;52:7023–7044. doi: 10.1088/0031-9155/52/23/017. [DOI] [PubMed] [Google Scholar]
  • 14.Shi CY, Xu XG, Stabin MG. SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Med Phys. 2008;35:3215–3224. doi: 10.1118/1.2936414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Segars JP. Development and Application of the New Dynamic NURBS-Based Cardiac-Torso (NCAT) Phantom [dissertation] University of North Carolina; 2001. [Google Scholar]
  • 16.International Commission on Radiological Protection. ICRP Publication 89: Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values. New York, NY: Elsevier Health; 2003. pp. 1–265. [Google Scholar]
  • 17.Stabin MG, Siegel JA. Physical models and dose factors for use in internal dose assessment. Health Phys. 2003;85:294–310. doi: 10.1097/00004032-200309000-00006. [DOI] [PubMed] [Google Scholar]
  • 18.Agostinelli S, Allison J, Amako K, et al. GEANT4: a simulation toolkit. Nucl Instrum Methods Phys Res A. 2003;506:250–303. [Google Scholar]
  • 19.Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. New York, NY: Society of Nuclear Medicine; 1991. pp. 1–128. [Google Scholar]
  • 20.Bielajew AF, Rogers DWO. PRESTA: the parameter reduced electron-step transport algorithm for electron Monte Carlo transport. Nucl Instrum Methods Phys Res B. 1986;18:165–171. 174–181. [Google Scholar]
  • 21.International Commission on Radiological Protection. Report of Committee II on Permissible Dose for Internal Radiation: ICRP Publication 2. New York, NY: Pergamon Press; 1959. pp. 1–233. [Google Scholar]
  • 22.Snyder W, Ford M, Warner G. Estimates of Specific Absorbed Fractions for Photon Sources Uniformly Distributed in Various Organs of a Heterogeneous Phantom: MIRD Pamphlet No. 5, Revised. New York, NY: Society of Nuclear Medicine; 1978. pp. 1–52. [Google Scholar]
  • 23.Guy MJ, Flux GD, Papavasileiou P, Flower MA, Ott RJ. RMDP: a dedicated package for I-131 SPECT quantification, registration and patient-specific dosimetry. Cancer Biother Radiopharm. 2003;18:61–69. doi: 10.1089/108497803321269331. [DOI] [PubMed] [Google Scholar]
  • 24.Stabin MG, Yoriyaz H. Photon specific absorbed fractions calculated in the trunk of an adult male voxel-based phantom. Health Phys. 2002;82:21–44. doi: 10.1097/00004032-200201000-00005. [DOI] [PubMed] [Google Scholar]
  • 25.Stabin MG, Konijnenberg M. Re-evaluation of absorbed fractions for photons and electrons in small spheres. J Nucl Med. 2000;41:149–160. [PubMed] [Google Scholar]
  • 26.Stabin MG, Eckerman KF, Ryman JC, Williams LE. Bremsstrahlung radiation dose in yttrium-90 therapy applications. J Nucl Med. 1994;35:1377–1380. [PubMed] [Google Scholar]
  • 27.Adult Reference Computational Phantoms: ICRP Publication 110—Annals of the ICRP Volume 39 Issue 2. Maryland Heights, MO: Elsevier; 2009. pp. 1–165. [DOI] [PubMed] [Google Scholar]
  • 28.Kramer R, Vieira JW, Khoury HJ, Lima FRA, Fuelle D. All about MAX: a male adult voxel phantom for Monte Carlo calculations in radiation protection dosimetry. Phys Med Biol. 2003;48:1239–1262. doi: 10.1088/0031-9155/48/10/301. [DOI] [PubMed] [Google Scholar]
  • 29.Zubal IG, Harrell CR, Smith EO, Smith AL, Krischlunas P. High resolution, MRI-based, segmented, computerized head phantom. In: S-Stelson AT, Stabin MG, Sparks RB, editors. Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium; ORAU; Oak Ridge, TN. 1996. pp. 319–364. [Google Scholar]
  • 30.Lee C, Lodwick D, Williams JL, Bolch WE. Hybrid computational phantoms of the 15-year male and female adolescent: applications to CT organ dosimetry for patients of variable morphometry. Med Phys. 2008;35:2366–2382. doi: 10.1118/1.2912178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Stabin MG, Eckerman KF, Bolch WE, Bouchet LG, Patton PW. Evolution and status of bone and marrow dose models. Cancer Biother Radiopharm. 2002;17:427–433. doi: 10.1089/108497802760363213. [DOI] [PubMed] [Google Scholar]
  • 32.Hunt JG, Watchman CJ, Bolch WE. Calculation of absorbed fractions to human skeletal tissues due to alpha particles using Monte Carlo and 3-D chord-based transport techniques. Radiat Prot Dosim. 2007;127:223–226. doi: 10.1093/rpd/ncm276. [DOI] [PubMed] [Google Scholar]
  • 33.International Commission on Radiological Protection. Human Alimentary Tract Model for Radiological Protection: ICRP Publication 100. Oxford, U.K.: Pergamon Press; 2007. pp. 1–327. [DOI] [PubMed] [Google Scholar]
  • 34.Sgouros G, Squeri S, Ballangrud ÅM, et al. Patient-specific, 3-dimensional dosimetry in non-Hodgkin’s lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response. J Nucl Med. 2003;44:260–268. [PubMed] [Google Scholar]

RESOURCES